Factors associated with return to work in patients with long-term disabilities due to neurological and neuropsychiatric disorders
Sign Up to like & getrecommendations! Published in 2017 at "Neuropsychological Rehabilitation"
DOI: 10.1080/09602011.2017.1395746
Abstract: ABSTRACT The current study explores factors predicting return to work in a sample of patients with neurological and neuropsychiatric disorders who have attended a prevocational readiness and social skills training programme many years after trauma.… read more here.
Keywords: neurological neuropsychiatric; term; term disabilities; long term ... See more keywords
Gene Therapy, A potential Therapeutic Tool for Neurological and Neuropsychiatric Disorders: Applications, Challenges and Future Prospective.
Sign Up to like & getrecommendations! Published in 2022 at "Current gene therapy"
DOI: 10.2174/1566523222666220328142427
Abstract: Neurological and neuropsychiatric disorders are the main risks for the health care system, exhibiting a huge socioeconomic load. The available range of pharmacotherapeutics mostly provides palliative consequences and fails to treat such conditions. The molecular… read more here.
Keywords: therapy potential; therapy; gene therapy; neuropsychiatric disorders ... See more keywords
Cation-Chloride Cotransporters KCC2 and NKCC1 as Therapeutic Targets in Neurological and Neuropsychiatric Disorders
Sign Up to like & getrecommendations! Published in 2023 at "Molecules"
DOI: 10.3390/molecules28031344
Abstract: Neurological diseases including Alzheimer’s, Huntington’s disease, Parkinson’s disease, Down syndrome and epilepsy, and neuropsychiatric disorders such as schizophrenia, are conditions that affect not only individuals but societies on a global scale. Current therapies offer a… read more here.
Keywords: cation chloride; chloride cotransporters; cotransporters kcc2; neuropsychiatric disorders ... See more keywords